| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/25/2004 | EP1200457B1 Cysteine protease inhibitors |
| 08/25/2004 | EP1078066B1 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 08/25/2004 | EP1077719B1 Vaccine delivery system based on gonococcal blebosomes |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP1037657A4 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 08/25/2004 | EP0893449B1 Antitumor substance extracted from hen-of-the-woods |
| 08/25/2004 | EP0881906B1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | EP0836619B1 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | EP0826051B1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 08/25/2004 | EP0816380B1 Ocif protein and methods for the production of the same |
| 08/25/2004 | EP0724632B1 Stem cell proliferation factor |
| 08/25/2004 | CN2635088Y Rapid biosealing hemostat |
| 08/25/2004 | CN1524124A Fibrin/fibrinogen-binding conjugate |
| 08/25/2004 | CN1524123A A soluble complex comprising a retroviral surface glycoprotein |
| 08/25/2004 | CN1524122A Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 08/25/2004 | CN1524092A Concatameric immunoadhesion |
| 08/25/2004 | CN1524090A Modified insulin with reduced immunogenicity |
| 08/25/2004 | CN1524088A A virus causing respiratory tract illness in susceptible mammals |
| 08/25/2004 | CN1524003A Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 08/25/2004 | CN1524002A Treatment or prophylaxis of insulin-producing cell graft rejection |
| 08/25/2004 | CN1523997A Stabilized interleukin 2 |
| 08/25/2004 | CN1523996A Methods for reducing immunogenicity of polypeptides |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523105A Serine proteinase and coded sequence thereof |
| 08/25/2004 | CN1523040A Fusion protein of human thymosin alpha1 and human composite interferon and preparation thereof |
| 08/25/2004 | CN1522759A Interferon and synergist combined pharmaceutical |
| 08/25/2004 | CN1522758A Topical compound interferon preparation |
| 08/25/2004 | CN1522757A Muscular amino acid and peptide nucleoside powder injection and its preparation method |
| 08/25/2004 | CN1522752A Animal brain extract and bitter gourd extract composition and its uses |
| 08/25/2004 | CN1163602C Fusion protein of tubercle bacillus antigen, and its use |
| 08/25/2004 | CN1163600C Process for preparing human proinsulin |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163596C Common phytase |
| 08/25/2004 | CN1163595C Process for inactivation of viruse with aid of acridine or acridine derivative |
| 08/25/2004 | CN1163513C Process high effectively producing BPI-Fc recombinant protein |
| 08/25/2004 | CN1163511C Yolk anti-interleukin -8 antibody, preparation method and its application |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163508C Process for producing inhibin of tumor blood vessel formation |
| 08/25/2004 | CN1163505C Anticancer polypeptide |
| 08/25/2004 | CN1163273C Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action |
| 08/25/2004 | CN1163272C Application of TNF antagonists as medicaments for treating septic diseases |
| 08/25/2004 | CN1163269C Medicinal composition containing aloe and its preparing process and application |
| 08/25/2004 | CN1163268C Preparation of oral collagen of gradient molecular weight |
| 08/25/2004 | CN1163267C Use of GLP-1 or analogs in treatment of stroke |
| 08/25/2004 | CN1163266C Eye drops for treating conjunctivitis and keratitis |
| 08/25/2004 | CN1163265C Pharmaceutical formulations of nerve growth factor |
| 08/25/2004 | CN1163264C Pharmaceutical compositions |
| 08/25/2004 | CN1163263C Polypeptide medicine as oral spray |
| 08/25/2004 | CN1163262C Osteogenic growth peptide medicine composite and its preparation and application |
| 08/25/2004 | CN1163260C Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 08/25/2004 | CN1163235C Antiviral linear polymer |
| 08/25/2004 | CN1163218C Skin-protecting cosmetics |
| 08/24/2004 | US6781030 By combining a genome from an activated donor cell with an activated enucleated oocyte to obtain a nuclear transfer embryo, and impregnating an animal with the nuclear transfer embryo in conditions suitable for gestation of a cloned animal |
| 08/24/2004 | US6781000 Alpha-ketoamide inhibitors of 20S proteasome |
| 08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
| 08/24/2004 | US6780986 Human zinc finger protein rip60 ; isolated nucleic acid molecules, expression vectors containing these molecules and host cells transfected with the molecules |
| 08/24/2004 | US6780984 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer |
| 08/24/2004 | US6780983 Polypeptide having water channel activity and DNA sequence |
| 08/24/2004 | US6780977 Therapeutic, diagnostic and research utilities for these polynucleotides and proteins |
| 08/24/2004 | US6780973 Pure eotaxin dna sequence and eotaxin polypeptide, and methods of using such dna and polypeptide to direct chemotaxis of eosinophils; methods are provided for the treatment diseases and disorders such as inflammation and tumorigenesis |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780971 Compositions for inhibiting the aggregation pathway of α-synuclein |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780969 Peptide for use in the treatment of infections of the urogenital systems |
| 08/24/2004 | US6780968 Neurokinin-2 (nk-2) antagonists useful in the treatment or prevention of disorders of the central nervous system, inflammatory diseases, asthma, or pain |
| 08/24/2004 | US6780892 Polymeric hemoglobin mutants |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780848 Use of GPE to protect glial cells or non-dopaminergic cells from death from neural injury or disease |
| 08/24/2004 | US6780847 Nucleotide sequences coding polypeptide for use in the treatment and prevention of viral infections |
| 08/24/2004 | US6780846 Membrane translocating peptide drug delivery system |
| 08/24/2004 | US6780845 Compounds and methods for cancer therapy |
| 08/24/2004 | US6780844 Calcium phosphopeptide complexes |
| 08/24/2004 | US6780843 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
| 08/24/2004 | US6780842 Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agent |
| 08/24/2004 | US6780841 Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same |
| 08/24/2004 | US6780839 Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 08/24/2004 | US6780838 Compounds for treating fungal pathologies of the oral cavity |
| 08/24/2004 | US6780837 Administering neurotrophic factor prior to, during or after damaging light exposure |
| 08/24/2004 | US6780836 Treating infection or ischemic wound in a mammal by administering relaxin, a hormone which induces secretion of vascular endothelial growth factor (vegf) |
| 08/24/2004 | US6780640 Human carboxypeptidases and polynucleotides encoding the same |
| 08/24/2004 | US6780639 Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
| 08/24/2004 | US6780628 Enzyme treatment |
| 08/24/2004 | US6780627 22438, 23553, 25278, and 26212 novel human sulfatases |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780625 Glycogen synthase kinase-3 inhibitors |
| 08/24/2004 | US6780614 Modified factor VIII cDNA and its use for the production of factor VIII |
| 08/24/2004 | US6780613 For identifying active domains and amino acid residues in polypeptides; prolactins; placental lactogens |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780609 High bone mass gene of 1.1q13.3 |
| 08/24/2004 | US6780608 Comprises chimeric polypeptides with varying calcium/caffeine sensitivity; for drug screening |
| 08/24/2004 | US6780595 Human Tbx20 gene and uses |
| 08/24/2004 | US6780438 Colostrum; promotes resistance to fresh infection, suppression of existing infection, stimulation of immune function, and the increase of tissue repair and healing. |
| 08/24/2004 | US6780434 Controlled release of metal cation-stabilized interferon |
| 08/24/2004 | US6780427 Superoxide dismutase or other antioxidant are directly applied in combination with polymeric hydrogels at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells |
| 08/24/2004 | US6780416 Bee venom polypeptides and methods of use thereof |
| 08/24/2004 | US6780412 Protein and monoclonal antibody specific thereto |
| 08/24/2004 | US6780410 Isolated cd39la polypeptide comprising specified amino acid sequence or mature protein portion thereof, having phosphohydrolase activity |
| 08/24/2004 | US6780409 Glutamic acid decarboxylase (GAD) based delivery system |